Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001819114-26-000001
Filing Date
2026-06-03
Accepted
2026-06-03 08:55:35
Documents
1
Effectiveness Date
2026-06-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7173
  Complete submission text file 0001819114-26-000001.txt   8289
Mailing Address 174 NASSAU STREET, SUITE 334 PRINCETON NJ 08542
Business Address 174 NASSAU STREET, SUITE 334 PRINCETON NJ 08542 609-658-9839
Optimeos Life Sciences, Inc. (Filer) CIK: 0001819114 (see all company filings)

EIN.: 814242793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-585980 | Film No.: 261059121